No profile data available.
Cocrystal Pharma, Inc. (COCP) is a healthcare company in the antiviral pharmaceuticals industry, based in Bothell, United States, with about 10 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$8.83 million. Its market capitalization was $20.61 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.
Cocrystal Pharma reported $0 in revenue for fiscal year 2025.
$20.61 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Tevogen Bio Holdings Inc. (TVGN), Serina Therapeutics, Inc. (SER), NanoViricides, Inc. (NNVC), GeoVax Labs, Inc. (GOVX).